Table 1.

Comparative Data on Treatment Outcomes: Scaffold-Based Systems vs. Conventional Therapies.

Treatment Method	Drug Delivery System	Key Outcomes	Advantages	Limitations
Conventional Chemotherapy	Intravenous	High systemic toxicity, non-specific	Established method, rapid distribution	Severe side effects, non-targeted
Nanoparticle-Based Delivery	Nanoparticles	Improved targeting, reduced toxicity	Enhanced EPR effect, customizable	Complex fabrication, potential toxicity
Scaffold-Based Delivery	3D Scaffolds	Sustained release, targeted delivery	Reduced side effects, multifunctional	Manufacturing complexity, potential immune response
Injectable Hydrogels	Self-assembling peptides	Prolonged drug release, localized delivery	Minimally invasive, biocompatible	Stability issues, potential for uneven drug distribution
Drug-Coated Scaffolds	Coated with anti-cancer drugs	Inhibition of cancer cell proliferation	Localized delivery, reduced systemic exposure	Risk of scaffold degradation, need for precise engineering